Department of Medicine

September 16, 2021

Structural variants in breast cancer risk genes

Vanderbilt epidemiologists conducted in-depth whole genome sequencing of breast cancer risk genes in Black women, who die at higher rates and have more aggressive disease, to discover mutations that may improve testing and treatment selection.

September 16, 2021

Chung receives early investigator award from ASCPT

Vanderbilt’s Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT).

September 10, 2021

Novel immunotherapy shows robust response for multiple myeloma

Vanderbilt research found that a novel immunotherapy demonstrated robust effectiveness in treating relapsed or refractory multiple myeloma.

September 8, 2021

New Clinician Spotlight: Jane Freedman

Jane Freedman, MD, has joined Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute.

September 7, 2021

Regulators of fat cell metabolism

Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity.

September 6, 2021

Medical diagnoses in musicians

Vanderbilt researchers mined electronic health records to find medical diagnoses that are more or less prevalent among musicians, who are present in large numbers in “Music City.”